Abcuro Secures $200M Series C to Advance Ulviprubart for IBM
Key Highlights Abcuro raises $200M in Series C funding led by New Enterprise Associates (NEA) with participation from…
Browsing Tag
Bain Capital Life Sciences
4 posts
Odyssey Therapeutics Appoints Timothy P. Walbert and Ian F. Smith to Board of Directors
Key Highlights Timothy P. Walbert: Former Chairman, President & CEO of Horizon Therapeutics, instrumental in $28.3 billion acquisition…
Areteia Secures $75M for Asthma Drug Expansion
Key Highlights $75 million in additional Series A financing brings total to $425 million for dexpramipexole’s global Phase III…
EyeBio Secures $130 Million in Extended Series A Funding, Paving the Way for Advanced Retinal Disease Therapies
Key Highlights Significant Funding Achievement: EyeBio successfully closes an extension to its Series A financing, totaling $130 million. Strategic…